Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. Landovitz RJ, Donnell D, Clement ME, Hanscom B, et al. N Engl J Med 2021;385:595-608.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Landovitz RJ, Donnell D, Clement ME, Hanscom B, et al. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. N Engl J Med 2021;385:595-608.
PMID: 34379922